Satellos Bioscience, Inc. (MSLE)
6.66
+0.31
(+4.88%)
USD |
NASDAQ |
Nov 06, 10:32
Satellos Bioscience Net Income (Quarterly) : -11.72M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.72M |
| March 31, 2026 | -9.768M |
| December 31, 2025 | -7.303M |
| September 30, 2025 | -5.821M |
| June 30, 2025 | -5.608M |
| March 31, 2025 | -6.141M |
| December 31, 2024 | -4.366M |
| September 30, 2024 | -6.634M |
| June 30, 2024 | -4.411M |
| March 31, 2024 | -5.13M |
| December 31, 2023 | -4.798M |
| September 30, 2023 | -2.665M |
| June 30, 2023 | -3.064M |
| March 31, 2023 | -1.232M |
| December 31, 2022 | -3.736M |
| September 30, 2022 | -1.454M |
| June 30, 2022 | -1.751M |
| March 31, 2022 | -1.670M |
| December 31, 2021 | -2.005M |
| September 30, 2021 | -8.933M |
| June 30, 2021 | -0.7004M |
| March 31, 2021 | -0.6806M |
| December 31, 2020 | -0.3284M |
| September 30, 2020 | -0.2138M |
| June 30, 2020 | -0.2303M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4884M |
| December 31, 2019 | -0.5146M |
| September 30, 2019 | -0.3904M |
| June 30, 2019 | -0.2879M |
| March 31, 2019 | -0.2694M |
| December 31, 2018 | -0.1864M |
| September 30, 2018 | -0.3193M |
| June 30, 2018 | -0.4823M |
| March 31, 2018 | -0.3292M |
| December 31, 2017 | -0.1683M |
| September 30, 2017 | -0.2465M |
| June 30, 2017 | -0.2479M |
| March 31, 2017 | -0.288M |
| December 31, 2016 | -0.171M |
| September 30, 2016 | -0.1601M |
| June 30, 2016 | -0.1499M |
| March 31, 2016 | -0.6263M |
| December 31, 2015 | -0.4253M |
| September 30, 2015 | -0.1264M |
| June 30, 2015 | -0.6007M |
| March 31, 2015 | -0.2034M |
| December 31, 2014 | 0.1376M |
| September 30, 2014 | -0.2651M |
| June 30, 2014 | -1.17M |
| March 31, 2014 | -0.5446M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -110.74M |
| Psyence Biomedical Ltd. | -0.7533M |
| Aurinia Pharmaceuticals, Inc. | 31.70M |
| enGene Therapeutics, Inc. | -32.50M |
| Medicus Pharma Ltd. | -8.440M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 11.72M |
| EPS Diluted (Quarterly) | -0.5625 |
| Enterprise Value | 70.49M |
| Earnings Yield | -29.76% |
| Normalized Earnings Yield | -29.76 |